[The usefulness of single photon emission computed tomography using N-isopropyl-p-[123I]-iodoamphetamine and 99mTc-hexamethylpropyleneamine oxime in patients with moyamoya disease].
Morita
K
K
Department of Nuclear Medicine, Kawasaki Medical School.
Ono
S
S
Fukunaga
M
M
Otsuka
N
N
Nagai
K
K
Furukawa
T
T
Muranaka
A
A
Mimura
H
H
Yanagimoto
S
S
Tomomitsu
T
T
D000293:Adolescent; D000328:Adult; D000662:Amphetamines; D001157:Arterial Occlusive Diseases / Q000000981:diagnostic imaging*; D001921:Brain / Q000000981:diagnostic imaging*; D002560:Cerebrovascular Circulation; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes; D020367:Iofetamine; D008297:Male; D008875:Middle Aged; D009072:Moyamoya Disease / Q000000981:diagnostic imaging* / Q000503:physiopathology; D015609:Organotechnetium Compounds; D010091:Oximes; D019690:Technetium Tc 99m Exametazime; D015899:Tomography, Emission-Computed, Single-Photon
D000662:Amphetamines; D007457:Iodine Radioisotopes; D015609:Organotechnetium Compounds; D010091:Oximes; D019690:Technetium Tc 99m Exametazime; D020367:Iofetamine